Our medical, nursing and allied health clinicians are increasingly involved in research to improve the care of our patients. This is reflected in the breadth of our research publications.

Reset
4290 results found

Pre-stroke physical activity and admission stroke severity: A systematic review

Hung, SH; Ebaid, D; Kramer, S; Werden, E; Baxter, H; Campbell, BCV; Brodtmann, A

(2021), Int. J. Stroke, 1009-1018

DOI: 10.1177/1747493021995271

Global impact of COVID-19 on stroke care

Nogueira, RG; Abdalkader, M; Qureshi, MM; Frankel, MR; Mansour, OY; Yamagami, H; Qiu, ZM; Farhoudi, M; Siegler, JE; Yaghi, S; Raz, E; Sakai, N; Ohara, N; Piotin, M; Mechtouff, L; Eker, O; Chalumeau, V; Kleinig, TJ; Pop, R; Liu, JM; Winters, HS; Shang, XJ; Vasquez, AR; Blasco, J; Arenillas, JF; Martinez-Galdamez, M; Brehm, A; Psychogios, MN; Lylyk, P; Haussen, DC; Al-Bayati, AR; Mohammaden, MH; Fonseca, L; Silva, ML; Montalverne, F; Renieri, L; Mangiafico, S; Fischer, U; Gralla, J; Frei, D; Chugh, C; Mehta, BP; Nagel, S; Mohlenbruch, M; Ortega-Gutierrez, S; Farooqui, M; Hassan, AE; Taylor, A; Lapergue, B; Consoli, A; Campbell, BCV; Sharma, M; Walker, M; Van Horn, N; Fiehler, J; Nguyen, HT; Nguyen, QT; Watanabe, D; Zhang, H; Le, HV; Nguyen, VQ; Shah, R; Devlin, T; Khandelwal, P; Linfante, I; Izzath, W; Lavados, PM; Olavarria, VV; Silva, GS; Sousa, AVD; Kirmani, J; Bendszus, M; Amano, T; Yamamoto, R; Doijiri, R; Tokuda, N; Yamada, T; Terasaki, T; Yazawa, Y; Morris, JG; Griffin, E; Thornton, J; Lavoie, P; Matouk, C; Hill, MD; Demchuk, AM; Killer-Oberpfalzer, M; Nahab, F; Altschul, D; Ramos-Pachon, A; de la Ossa, NP; Kikano, R; Boisseau, W; Walker, G; Cordina, SM; Puri, A; Kuhn, AL; Gandhi, D; Ramakrishnan, P; Novakovic-White, R; Chebl, A; Kargiotis, O; Czap, A; Zha, A; Masoud, HE; Lopez, C; Ozretic, D; Al-Mufti, F; Zie, WJ; Duan, ZH; Yuan, ZZ; Huang, WG; Hao, YG; Luo, J; Kalousek, V; Bourcier, R; Guile, R; Hetts, S; Al-Jehani, HM; AlHazzani, A; Sadeghi-Hokmabadi, E; Teleb, M; Payne, J; Lee, JS; Hong, JM; Sohn, SI; Hwang, YH; Shin, DH; Roh, HG; Edgell, R; Khatri, R; Smith, A; Malik, A; Liebeskind, D; Herial, N; Jabbour, P; Magalhaes, P; Ozdemir, AO; Aykac, O; Uwatoko, T; Dembo, T; Shimizu, H; Sugiura, Y; Miyashita, F; Fukuda, H; Miyake, K; Shimbo, J; Sugimura, Y; Beer-Furlan, A; Joshi, K; Catanese, L; Abud, DG; Neto, OP; Mehrpour, M; Al Hashmi, A; Saqqur, M; Mostafa, A; Fifi, JT; Hussain, S; John, S; Gupta, R; Sivan-Hoffmann, R; Reznik, A; Sani, AF; Geyik, S; Akil, ECR; Churojana, A; Ghoreishi, A; Saadatnia, M; Sharifipour, E; Ma, A; Faulder, K; Wu, T; Leung, L; Malek, A; Voetsch, B; Wakhloo, A; Rivera, R; Iman, DMB; Pikula, A; Lioutas, VA; Thomalla, G; Birnbaum, L; Machi, P; Bernava, G; McDermott, M; Kleindorfer, D; Wong, K; Patterson, MS; Fiorot, JA; Huded, V; Mack, W; Tenser, M; Eskey, C; Multani, S; Kelly, M; Janardhan, V; Cornett, O; Singh, V; Murayama, Y; Mokin, M; Yang, PF; Zhang, XX; Yin, CG; Han, HX; Peng, Y; Chen, WH; Crosa, R; Frudit, ME; Pandian, JD; Kulkarni, A; Yagita, Y; Takenobu, Y; Matsumaru, Y; Yamada, S; Kono, R; Kanamaru, T; Yamazaki, H; Sakaguchi, M; Todo, K; Yamamoto, N; Sonoda, K; Yoshida, T; Hashimoto, H; Nakahara, I; Cora, E; Volders, D; Ducroux, C; Shoamanesh, A; Ospel, J; Kaliaev, A; Ahmed, S; Rashid, U; Rebello, LC; Pereira, VM; Fahed, R; Chen, M; Sheth, SA; Palaiodimou, L; Tsivgoulis, G; Chandra, R; Koyfman, F; Leung, T; Khosravani, H; Dharmadhikari, S; Frisullo, G; Calabresi, P; Tsiskaridze, A; Lobjanidze, N; Grigoryan, M; Czlonkowska, A; de Sousa, DA; Demeestere, J; Liang, C; Sangha, N; Lutsep, HL; Ayo-Martin, O; Cruz-Culebras, A; Tran, AD; Young, CY; Cordonnier, C; Caparros, F; De Lecinana, MA; Fuentes, B; Yavagal, D; Jovin, T; Spelle, L; Moret, J; Khatri, P; Zaidat, O; Raymond, J; Martins, S; Nguyen, T

(2021), Int. J. Stroke, 573-584

DOI: 10.1177/1747493021991652

Editorial: Intracranial Bleeding After Reperfusion Therapy in Acute Ischemic Stroke

Mishra, NK; Leigh, R; Campbell, BCV

(2021), Front. Neurol.

DOI: 10.3389/fneur.2021.745993

COVID-19 Pandemic Impact on Care for Stroke in Australia: Emerging Evidence From the Australian Stroke Clinical Registry

Cadilhac, DA; Kim, J; Tod, EK; Morrison, JL; Breen, SJ; Jaques, K; Grimley, R; Jones, B; Cloud, GC; Kleinig, T; Hillier, S; Castley, H; Lindley, RI; Lannin, NA; Middleton, S; Yan, B; Hill, K; Clissold, BB; Mitchell, PJ; Anderson, CS; Faux, SG; Campbell, BCV

(2021), Front. Neurol.

DOI: 10.3389/fneur.2021.621495

Altered Functional Connectivity and Cognition Persists 4 Years After a Transient Ischemic Attack or Minor Stroke

Nicolas, K; Goodin, P; Visser, MM; Michie, PT; Bivard, A; Levi, C; Parsons, MW; Karayanidis, F

(2021), Front. Neurol.

DOI: 10.3389/fneur.2021.612177

Ischemic Penumbra: A Personal View

Davis, SM; Donnan, GA

(2021), Cerebrovasc. Dis., 656-665

DOI: 10.1159/000519730

Motor neuroprosthesis implanted with neurointerventional surgery improves capacity for activities of daily living tasks in severe paralysis: first in-human experience

Oxley, TJ; Yoo, PE; Rind, GS; Ronayne, SM; Lee, CMS; Bird, C; Hampshire, V; Sharma, RP; Morokoff, A; Williams, DL; MacIsaac, C; Howard, ME; Irving, L; Vrljic, I; Williams, C; John, SE; Weissenborn, F; Dazenko, M; Balabanski, AH; Friedenberg, D; Burkitt, AN; Wong, YT; Drummond, KJ; Desmond, P; Weber, D; Denison, T; Hochberg, LR; Mathers, S; O'Brien, TJ; May, CN; Mocco, J; Grayden, DB; Campbell, BCV; Mitchell, P; Opie, NL

(2021), J. NeuroInterventional Surg., 102-108

DOI: 10.1136/neurintsurg-2020-016862

Circulating tumor DNA for malignant peripheral nerve sheath tumors in neurofibromatosis type 1

Jones, J; Cain, S; Pesic-Smith, J; Choong, PFM; Morokoff, AP; Drummond, KJ; Dabscheck, G

(2021), J. Neuro-Oncol., 265-274

DOI: 10.1007/s11060-021-03846-z

Pretreatment neutrophil-to-lymphocyte/monocyte-to-lymphocyte ratio as prognostic biomarkers in glioma patients

Chim, ST; Sanfilippo, P; O'Brien, TJ; Drummond, KJ; Monif, M

(2021), J. Neuroimmunol.

DOI: 10.1016/j.jneuroim.2021.577754

Life after surgical resection of a low-grade glioma: A prospective cross-sectional study evaluating health-related quality of life

Teng, KX; Price, B; Joshi, S; Alukaidey, L; Shehab, A; Mansour, K; Toor, GS; Angliss, R; Drummond, K

(2021), J. Clin. Neurosci., 259-267

DOI: 10.1016/j.jocn.2021.03.038

Ischaemic monomelic neuropathy: A rare cause of unilateral foot drop

Kweh, BTS; Jalil, MAF; Rodrigues, E; Goh, D; Yuen, TI

(2021), J. Clin. Neurosci., 36-38

DOI: 10.1016/j.jocn.2021.02.030

Assessment of the DTI-ALPS Parameter Along the Perivascular Space in Older Adults at Risk of Dementia

Steward, CE; Venkatraman, VK; Lui, E; Malpas, CB; Ellis, KA; Cyarto, EV; Vivash, L; O'Brien, TJ; Velakoulis, D; Ames, D; Masters, CL; Lautenschlager, NT; Bammer, R; Desmond, PM

(2021), J. Neuroimaging, 569-578

DOI: 10.1111/jon.12837

Predictors of New-Onset Epilepsy in People With Younger-Onset Neurocognitive Disorders

Wang, XS; Loi, SM; Foster, E; Chen, ZB; Velakoulis, D; Kwan, P

(2021), Front. Aging Neurosci.

DOI: 10.3389/fnagi.2021.637260

Psychiatric symptoms are the strongest predictors of quality of life in patients with drug-resistant epilepsy or psychogenic nonepileptic seizures

Johnstone, B; Malpas, CB; Velakoulis, D; Kwan, P; O'Brien, TJ

(2021), Epilepsy Behav.

DOI: 10.1016/j.yebeh.2021.107861

Psychiatric and cognitive characteristics of older adults admitted to a Video-EEG monitoring (VEM) unit

Hew, A; Lloyd, M; Rayner, G; Matson, A; Rychkova, M; Ali, R; Winton-Brown, T; Perucca, P; Kwan, P; O'Brien, TJ; Velakoulis, D; Malpas, CB; Loi, SM

(2021), Epilepsy Behav.

DOI: 10.1016/j.yebeh.2021.107987

Cognitive profiles in patients with epileptic and nonepileptic seizures evaluated using a brief cognitive assessment tool

Dilcher, R; Malpas, CB; Walterfang, M; Kwan, P; O'Brien, TJ; Velakoulis, D; Vivash, L

(2021), Epilepsy Behav.

DOI: 10.1016/j.yebeh.2020.107643

Clinical predictors of discordance between screening tests and psychiatric assessment for depressive and anxiety disorders among patients being evaluated for seizure disorders

Holper, S; Foster, E; Lloyd, M; Rayner, G; Rychkova, M; Ali, R; Winton-Brown, TT; Velakoulis, D; O'Brien, TJ; Kwan, P; Malpas, CB

(2021), Epilepsia, 1170-1183

DOI: 10.1111/epi.16871

Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trial

Vivash, L; Bertram, KL; Malpas, CB; Marotta, C; Harding, IH; Kolbe, S; Fielding, J; Clough, M; Lewis, SJG; Tisch, S; Evans, AH; O'Sullivan, JD; Kimber, T; Darby, D; Churilov, L; Law, M; Hovens, CM; Velakoulis, D; O'Brien, TJ

(2021), BMJ Open

DOI: 10.1136/bmjopen-2021-055019

Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives

Eratne, D; Janelidze, S; Malpas, CB; Loi, S; Walterfane, M; Merritt, A; Diouf, I; Blennow, K; Zetterberg, H; Cilia, B; Warman, C; Bousman, C; Everall, I; Zalesky, A; Jayaram, M; Thomas, N; Berkovic, SF; Hansson, O; Velakoulis, D; Pantelis, C; Santillo, A

(2021), Aust. N. Z. J. Psych.

DOI: 10.1177/00048674211058684

Brain atrophy and lesion burden are associated with disability progression in a multiple sclerosis real-world dataset using only T2-FLAIR: The NeuroSTREAM MSBase study

Barnett, M; Bergsland, N; Weinstock-Guttman, B; Butzkueven, H; Kalincik, T; Desmond, P; Gaillard, F; van Pesch, V; Ozakbas, S; Rojas, JI; Boz, C; Altintas, A; Wang, CY; Dwyer, MG; Yang, S; Jakimovski, D; Kyle, K; Ramasamy, DP; Zivadinov, R

(2021), NeuroImage-Clin.

DOI: 10.1016/j.nicl.2021.102802

No evidence for loss of natalizumab effectiveness with every-6-week dosing: a propensity score-matched comparison with every-4-week dosing in patients enrolled in the Tysabri Observational Program (TOP)

Butzkueven, H; Kappos, L; Spelman, T; Trojano, M; Wiendl, H; Su, R; Liao, S; Hyde, R; Licata, S; Ho, PR; Campbell, N

(2021), Ther. Adv. Neurol. Disord.

DOI: 10.1177/17562864211042458

Evolution of Brain Volume Loss Rates in Early Stages of Multiple Sclerosis

Uher, T; Krasensky, J; Malpas, C; Bergsland, N; Dwyer, MG; Havrdova, EK; Vaneckova, M; Horakova, D; Zivadinov, R; Kalincik, T

(2021), Neurol.-Neuroimmunol. Neuroinflammation

DOI: 10.1212/NXI.0000000000000979

High BMI in Youths as a Modifiable Risk Factor for Multiple Sclerosis Weighing Up the Evidence

Kalincik, T; Tremlett, H; Ascherio, A

(2021), Neurology, 1057-1058

DOI: 10.1212/WNL.0000000000012966

Has the Time Come to Revisit Our Standard Measures of Disability Progression in Multiple Sclerosis?

Kalincik, T; Sormani, MP; Tur, C

(2021), Neurology, 12-13

DOI: 10.1212/WNL.0000000000011120

Effects of High- and Low-Efficacy Therapy in Secondary Progressive Multiple Sclerosis

Roos, I; Leray, E; Casey, R; Horakova, D; Havrdova, E; Izquierdo, G; Madueno, SE; Patti, F; Edan, G; Debouverie, M; Pelletier, J; Ozakbas, S; Amato, MP; Clavelou, P; Grammond, P; Boz, C; Buzzard, K; Skibina, O; Ciron, J; Gerlach, O; Grand'Maison, F; Lechner-Scott, J; Malpas, C; Butzkueven, H; Vukusic, S; Kalincik, T

(2021), Neurology, E869-E880

DOI: 10.1212/WNL.0000000000012354

Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years

Kalincik, T; Diouf, I; Sharmin, S; Malpas, C; Spelman, T; Horakova, D; Havrdova, EK; Trojano, M; Izquierdo, G; Lugaresi, A; Prat, A; Girard, M; Duquette, P; Grammond, P; Jokubaitis, V; Van der Walt, A; Grand'Maison, F; Sola, P; Ferraro, D; Shaygannejad, V; Alroughani, R; Hupperts, R; Terzi, M; Boz, C; Lechner-Scott, J; Pucci, E; Van Pesch, V; Granella, F; Bergamaschi, R; Spitaleri, D; Slee, M; Vucic, S; Ampapa, R; McCombe, P; Ramo-Tello, C; Prevost, J; Olascoaga, J; Cristiano, E; Barnett, M; Saladino, ML; Sanchez-Menoyo, JL; Hodgkinson, S; Rozsa, C; Hughes, S; Moore, F; Shaw, C; Butler, E; Skibina, O; Gray, O; Kermode, A; Csepany, T; Singhal, B; Shuey, N; Piroska, I; Taylor, B; Simo, M; Sirbu, CA; Sas, A; Butzkueven, H

(2021), Neurology, E783-E797

DOI: 10.1212/WNL.0000000000011242

Association Between Cognitive Trajectories and Disability Progression in Patients With Relapsing-Remitting Multiple Sclerosis

Merlo, D; Stankovich, J; Bai, C; Kalincik, T; Zhu, C; Gresle, M; Lechner-Scott, J; Kilpatrick, T; Barnett, M; Taylor, B; Darby, D; Butzkueven, H; Van der Walt, A

(2021), Neurology, E2020-E2031

DOI: 10.1212/WNL.0000000000012850

Comparative effectiveness of rituximab in multiple sclerosis

Kalincik, T; Sormani, MP

(2021), Nat. Rev. Neurol., 3-4

DOI: 10.1038/s41582-020-00412-5

Real-world effectiveness of cladribine for Australian patients with multiple sclerosis: An MSBase registry substudy

Lizak, N; Hodgkinson, S; Butler, E; Lechner-Scott, J; Slee, M; McCombe, PA; Shaw, C; Skibina, O; Vucic, S; Shuey, N; Barnett, MH; Parratt, J; Butzkueven, H; Jack, D; Fabris, J; Kalincik, T

(2021), Mult. Scler. J., 465-474

DOI: 10.1177/1352458520921087

Prediction of on-treatment disability worsening in RRMS with the MAGNIMS score

Kunchok, A; Lechner-Scott, J; Granella, F; Trojano, M; Alroughani, R; Sola, P; Ferraro, D; Lugaresi, A; Onofrj, M; Ozakbas, S; Izquierdo, G; Grammond, P; Sanchez-Menoyo, JL; Van Wijmeersch, B; Boz, C; Pucci, E; McCombe, P; Grand'Maison, F; Spitaleri, D; Vucic, S; Hupperts, R; Jokubaitis, V; Sormani, MP; Butzkueven, H; Kalincik, T

(2021), Mult. Scler. J., 695-705

DOI: 10.1177/1352458520936823

21 22 23 24 25 26 27 28 29